Key Financial Data Of Reporting Company

Oncolys BioPharma Inc. - Filing #7712397

Concept As at
2019-03-31
2019-01-01 to
2019-03-31
As at
2018-12-31
2018-01-01 to
2018-12-31
As at
2018-03-31
2018-01-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
48,383,000 JPY
168,549,000 JPY
33,874,000 JPY
Ordinary profit (loss)
-359,220,000 JPY
-1,230,105,000 JPY
-310,439,000 JPY
Profit (loss)
-360,185,000 JPY
-1,233,846,000 JPY
-311,386,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
6,437,421,000 JPY
6,402,658,000 JPY
5,802,444,000 JPY
Total number of issued shares
13,449,800 xbrli:shares
13,346,000 xbrli:shares
11,086,000 xbrli:shares
Net assets
2,612,972,000 JPY
2,901,153,000 JPY
2,596,831,000 JPY
Total assets
3,310,500,000 JPY
3,430,112,000 JPY
3,148,825,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-26.91
-104.55
-28.09
Diluted earnings per share
Equity-to-asset ratio
0.786 xbrli:pure
0.843 xbrli:pure
0.821 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.